Skip to content
← Full study record

NCT04548648 · MORE INFO

Limitations, agreements, and source contact

A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas · Source last updated 2026-06-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Subcontractor agrees that the first publication of the Study results will be made by Institution as a multi-site publication. Subcontractor can publish its site-specific results after Institution's publication, 12 months post-study completion, or upon Institution's notice of completion. Subcontractor must provide Institution 30 days for manuscript review and may delay publication for 45 days for institution's patent filing. Institution will register the Study and post results as required by law.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
This study did not achieve its target enrollment, which may limit the generalizability of the findings to broader populations.
point Of Contact
email
Melahat_Canter@med.unc.edu
organization
UNC Lineberger Comprehensive Cancer Center
phone
(919) 962-0000
title
Melahat Canter
Complete source fields
certain Agreement
other Details
Subcontractor agrees that the first publication of the Study results will be made by Institution as a multi-site publication. Subcontractor can publish its site-specific results after Institution's publication, 12 months post-study completion, or upon Institution's notice of completion. Subcontractor must provide Institution 30 days for manuscript review and may delay publication for 45 days for institution's patent filing. Institution will register the Study and post results as required by law.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
limitations And Caveats
description
This study did not achieve its target enrollment, which may limit the generalizability of the findings to broader populations.
point Of Contact
email
Melahat_Canter@med.unc.edu
organization
UNC Lineberger Comprehensive Cancer Center
phone
(919) 962-0000
title
Melahat Canter

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice